Press "Enter" to skip to content

Global Pharmaceutical Contract Manufacturing (CMO) Market 2021 Recent Study including Growth Factors, Applications, Regional Analysis, Key Players and Forecasts

Pharmaceutical Contract Manufacturing (CMO)

Pharmaceutical Contract Manufacturing (CMO) Market” report provides strategic supports mentioned by the business specialists with market sources, amount of manufacturing cost structure, raw materials, forecasts, turnover, manufacturing outlays, latest market trends, labor cost, demands and much more. Pharmaceutical Contract Manufacturing (CMO) market report covers a comprehensive market structure through the globe with an in-depth study of major dynamics (Drivers, Challenges, Opportunities).  

Request a sample copy of the report –

Key Market Trends:

Active Pharmaceutical Ingredient (API) Manufacturing is Expected to Register a Significant Growth

– The demand for API manufacturing has witnessed a sustained rise in the past few years, and it is expected to continue growing steadily, with further patent expiries expected in the future and a subsequent increase in global generic production capacities. Most of the companies in this industry are increasingly focusing on the development of biological APIs, which is driving the API market. The general prescription drug sub-segment occupies a major share in the API manufacturing segment, as compared to OTC drugs.
– Other factors driving the growth of the API segment includes stringent government initiatives in the healthcare sector, innovation in biologics, and rise in the incidence of cancer and age-related diseases. However, strict an regulatory policies may hinder the segment’s growth.
– Captive manufacturers are currently leading the API market; however, they are slowly expected to lose their market share to contract manufacturers toward the end of the forecast period. This is due to the complex and expensive in-house manufacturing of API and increasing competition from emerging players in this industry.The increasing emphasis on high-potency APIs is driving the growth of the segment. The novel technologies for HPAPIs can potentially change the in-out balance of CMOs in this fast-growing segment.
– As the big pharma companies continue to scale down on manufacturing, greater opportunities for the CMOs are expected, both in the biopharmaceutical and small molecule API segments.

is Expected to Account for a Major Share

– The United States, which in in North America, is the world’s largest market for drugs and accounts for almost half of the R&D spending in pharmaceutical and biotechnology markets. Hence, CMOs play a critical role in this market and have invested in new facilities and technologies to cater to a wide range of outsourcers.The is expected to face strong competition from Asia-Pacific CMO providers, especially in solid dose formation.
– The consolidation of CMOs is expected to occur within the next five years, as the competitors will either leave the industry, or abandon a specific area within the industry, or go out of business. This improves the pricing power of value-added CMOs.
– Companies, such as Catalent and Patheon, have an established customer base in the and are leaders in oral and sterile dose formulations. These companies have been aggressive in expanding their products/services/capabilities through strategic alliances. With the recent acquisition of Confab, DPT Laboratories has become the global leader in prescription semi-solid and liquid formulations, acquiring proprietary products.

Market Overview:

  • The pharmaceutical contract manufacturing (CMO) market is expected to register a CAGR of over 7.75% during the forecast period 2019 – 2024. With the growing demand for generic medicines and biologics, the capital-intensive nature of the business, and the complex manufacturing requirements, many pharmaceutical companies have identified the potential profitability in contracting with a CMO (contract manufacturing outsourcing) for both clinical and commercial stage manufacturing. Additionally, pharmaceutical companies have been directing their priorities toward the core areas of competency, and hence, prefer not to dispense available resources, expertise, and technology on formulating the final dose of medicines.
  • – In order to adapt to the paradigm shift in the biotechnology industry and the present biopharmaceutical industry trends, CMOs have decided to move away from solely renting manufacturing units to a business model that offers extensive development and production support.
  • – CMOs and contract development and manufacturing organizations (CDMO) individually or together have started offering many specialized, value-added services for customers with early-stage development needs and for those who require support to generate a biologics license application (BLA) enabling process validation data package.
  • – CMOs have begun offering early development support to their customers, along with fully integrated services, which include specialized services like aseptic fill–finish. Though the concept of CDMO was introduced earlier, it has been fully realized over the last few years.
  • – The costs invested in R&D are continuously increasing, and yet the useful results returned from these processes are becoming rarer. Many companies have realized that moving this part of the business overseas and taking advantage of the still-emerging pharmaceutical markets is an effective method of cutting costs.
  • – Despite the existing evidence regarding cost savings and competences that can be accrued, many companies are reluctant to give up that control, going so far as to state that logistics are a core competency for the company. However, that scenario seems to be changing slowly.

    Key Manufacturers Like 

  • Pfizer Inc.
  • Baxter BioPharma solutions
  • Boehringer Ingelheim International GmbH.
  • Jubilant Life Sciences Limited
  • Recipharm AB
  • Catalent Inc.
  • Recipharm AB
  • Patheon Inc
  • Famar S.A.
  • Aenova Group.

    Scope of the Report:

  • A contract manufacturing organization (CMO), called a contract development and manufacturing organization (CDMO), is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing. This allows major pharmaceutical companies to outsource those aspects of the business, which can help with scalability or can allow the major company to focus on drug discovery and drug marketing

    Pharmaceutical Contract Manufacturing (CMO) market report focuses on the latest trends in the global and regional spaces on all the significant components, including the capacity, cost, price, technology, supplies, production, profit, and competition. Moreover, the old data and present development of the Pharmaceutical Contract Manufacturing (CMO) market have been given in the scope of the report. The latest trends, product portfolio, demographics, geographical segmentation, and regulatory framework of the Pharmaceutical Contract Manufacturing (CMO) market have also been involved in the study.

    Market Dynamics: –

    • Drivers: (Developing regions and growing markets)
    • Limitations: (Regional, Key Player facing Issues, Future Barriers for growth)
    • Opportunities: (Regional, Growth Rate, Competitive, Consumption)

    Inquire Or Share Your Questions If Any Before The Purchasing This Report –

    Key Questions Answered in Market Report: –

    • What will the market growth rate, Overview and Analysis by Type of Pharmaceutical Contract Manufacturing (CMO) market in 2023?
    • What are the key factors driving, Analysis by Applications and Countries Pharmaceutical Contract Manufacturing (CMO) market?
    • What are Dynamics, This Overview Includes Analysis of Scope, and price analysis of top Vendors Profiles of Pharmaceutical Contract Manufacturing (CMO) ?
    • Who are Opportunities, Risk and Driving Force of Pharmaceutical Contract Manufacturing (CMO) market? Knows Upstream Raw Materials Sourcing and Downstream Buyers
    • Who are the opportunities and threats faced by the vendors in Pharmaceutical Contract Manufacturing (CMO) space? Business Overview by Type, Applications, Gross Margin and Market Share
    • What are the Pharmaceutical Contract Manufacturing (CMO) market opportunities, market risk and market overview of the Market?

    Lastly, the Global Pharmaceutical Contract Manufacturing (CMO) Market Research covers a complete market structure across the world with a comprehensive analysis of major key factors. This report provides planned orientations referred by the industry experts.

    Purchase This Report (Price 4250 USD for single user license) –   

    Study objectives of Pharmaceutical Contract Manufacturing (CMO) Market Report:

    • To provide a detailed analysis of the market structure along with the Pharmaceutical Contract Manufacturing (CMO) market forecast of various segments and sub-segments of the Pharmaceutical Contract Manufacturing (CMO) market
    • To provide insights into factors influencing and affecting market growth
    • To provide historical, current, and forecast revenue of market segments based on material, type, design, and end user
    • To provide historical, current, and forecast revenue of market segments and sub-segments with respect to regional markets and key countries
    • To provide strategic profiling of key players in the market, comprehensively analyzing their market shares, core competencies, and drawing a competitive landscape for the market
    • To provide economic factors, technology and Pharmaceutical Contract Manufacturing (CMO) market trends that influence the global Pharmaceutical Contract Manufacturing (CMO) market

    Detailed TOC of Pharmaceutical Contract Manufacturing (CMO) Market Report 2019-2024:

    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study



    4.1 Market Overview
    4.2 Introduction to Market Drivers and Restraints
    4.3 Market Drivers
    4.3.1 Increasing Outsourcing Volume By Big Pharmaceutical Companies
    4.3.2 Expansion In The Service Offering Of CMOS
    4.3.3 Advent Of CDMO Model Into The Market
    4.3.4 Increasing Investments In R&D
    4.4 Market Restraints
    4.4.1 Increasing Lead Time & Logistics Costs
    4.4.2 Stringent Regulatory Requirements
    4.4.3 Capacity Utilisation Issues Affecting The Profitability Of Cmos
    4.5 Value Chain / Supply Chain Analysis
    4.6 Industry Attractiveness Porters Five Force Analysis
    4.6.1 Threat of New Entrants
    4.6.2 Bargaining Power of Buyers/Consumers
    4.6.3 Bargaining Power of Suppliers
    4.6.4 Threat of Substitute Products
    4.6.5 Intensity of Competitive Rivalry
    4.7 Technology Snapshot
    4.7.1 Dosage Formulation Technologies
    4.7.2 Dosage Forms by Route of Administration

    5.1 By Type
    5.1.1 Active Pharmaceutical Ingredient (API) Manufacturing
    5.1.2 Finished Dosage Formulation (FDF) Development & Manufacturing
    5.1.3 Secondary Packaging
    5.2 Geography
    5.2.1 North America US Canada
    5.2.2 Germany UK France Italy Rest of
    5.2.3 Asia Pacific China Japan India Australia Rest of Asia-Pacific
    5.2.4 Latin America Brazil Argentina Mexico Rest of Latin America
    5.2.5 Middle East and Africa UAE Saudi Arabia South Africa Nigeria Rest of Middle East and Africa

    6.1 Company Profiles
    6.1.1 Pfizer Inc.
    6.1.2 Baxter BioPharma solutions
    6.1.3 Boehringer Ingelheim International GmbH.
    6.1.4 Jubilant Life Sciences Limited
    6.1.5 Recipharm AB
    6.1.6 Catalent Inc.
    6.1.7 Recipharm AB
    6.1.8 Patheon Inc
    6.1.9 Famar S.A.
    6.1.10 Aenova Group



    Purchase This Report (Price 4250 USD for single user license) –


    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other report :
    Automatic Tracking Cameras Market 2021: Global Companies, Consumption, Drivers, Trends, Forces Analysis, Revenue, Challenges, Top Leading Countries and Global Forecast 2027

    Global Surveillance Cameras Market 2021 by Key Players, Industry Overview, Segmentation, Supply Chain and Analysis to 2026

    Global Tidal Energy Market 2021 Size, Share, Growth, Trends and Forecast, Business Opportunities and Future Investments by 2026

    Bone Grafts and Substitutes Market 2021| Segmentation and Analysis by Recent Trends, Market Dynamics and Scope, Development and Growth by Trending Regions by 2030

    Boutique Amplifiers Market 2021: Opportunities, Size, Trends, Growth Status, Competitive Landscape by Forecast to 2027

    Tomato Juice Market 2021: Market Share, Global Trend, Industry Demand, Business Growth, Top Key Players, Business Statistics and Research Methodology by Forecast to 2027

    Global Electric Pressure Washer Market 2021|Analysis with Key Players, Types, Application, Trends and Forecasts by 2026

    Cancer Vaccines Market Supply, Market Size, Share, Growth, Consumption, Cost and Profit analysis and forecast to 2030

    Hair Building Fibers Market 2021: Top Key Players, Sales Revenue, Development Status, Emerging Technologies, Opportunity Assessment and Industry Expansion Strategies 2027

    Micro Servo Motor Market 2021: Leading Company Analysis, Share, Growth, Size, Opportunities, Trends, Regional Overview, and Key Country Forecast to 2027

    Global Ammonia Sulfate Market 2021|Analysis with Key Players, Types, Application, Trends and Forecasts by 2026

    Global Computer Mice Market 2021|Market Size, Overview, Cost Structure Analysis, Growth Opportunities and Forecast to 2027

    Global 1-Bowl Kitchen Sinks Market 2021|Growth, Market Share, Production, Revenue, Price and Gross Margin Analysis and Forecasts to 2026

    Automotive Green Glass Market 2021: Global Companies, Consumption, Drivers, Trends, Forces Analysis, Revenue, Challenges, Top Leading Countries and Global Forecast 2027